| 000 | 01383 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516081412.0 | ||
| 264 | 0 | _c20120817 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/j.1365-2265.2012.04373.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhitelaw, B C | |
| 245 | 0 | 0 |
_aTemozolomide in the management of dopamine agonist-resistant prolactinomas. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cJun 2012 |
||
| 300 |
_a877-86 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProlactinoma _xdrug therapy |
| 650 | 0 | 4 | _aTemozolomide |
| 700 | 1 | _aDworakowska, D | |
| 700 | 1 | _aThomas, N W | |
| 700 | 1 | _aBarazi, S | |
| 700 | 1 | _aRiordan-Eva, P | |
| 700 | 1 | _aKing, A P | |
| 700 | 1 | _aHampton, T | |
| 700 | 1 | _aLandau, D B | |
| 700 | 1 | _aLipscomb, D | |
| 700 | 1 | _aBuchanan, C R | |
| 700 | 1 | _aGilbert, J A | |
| 700 | 1 | _aAylwin, S J B | |
| 773 | 0 |
_tClinical endocrinology _gvol. 76 _gno. 6 _gp. 877-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.2012.04373.x _zAvailable from publisher's website |
| 999 |
_c21581332 _d21581332 |
||